Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes
scientific article published in July 2009
Author/s
author: Philippe Gabriel Steg, Christopher B. Granger, Salim Yusuf, Susan Chrolavicius, Petr Widimský, Campbell D Joyner, Sanjit S Jolly, William E Boden, Keith Fox, Shamir Mehta, David P Faxon, Vicent Valentin
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.